Targeted cancer therapy: Can it be the key to achieve complete cure of cancer without side effects? A reveiw

International Journal of Pharmaceutical Sciences Review and Research

Volumn 7, Issue 2, 2011, Pages 19-27

  Maduri, Sairam ^a  

^a JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

Author keywords

Angiogenesis; Aptamers; Cancer antigens; Chemotherapy; Liposomes; Monoclonal antibody; Nanoparticles; Polymer drug conjugates; Receptors

Indexed keywords

(3 IODOBENZYL)GUANIDINE; ALEMTUZUMAB; ANGIOGENESIS INHIBITOR; APTAMER; BEVACIZUMAB; CAMPATH R; CANNABINOID; CARBOXYMETHYLDEXTRAN; CELL RECEPTOR; CETUXIMAB; CISPLATIN; CYCLODEXTRIN; DOCETAXEL; DOXORUBICIN; FULVESTRANT; GEFITINIB; GEMTUZUMAB OZOGAMICIN; HERCEPTIN R; IBRITUMOMAB TIUXETAN; IMATINIB; LIPOSOME; MACROGOL; MONOCLONAL ANTIBODY; MYLOTARG R; N (2 HYDROXYPROPYL)METHACRYLAMIDE; NANOPARTICLE; PACLITAXEL; PEGAMOTECAN; RITUXAN R; RITUXIMAB; SMALL INTERFERING RNA; TRASTUZUMAB; TUMOR ANTIGEN; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZEVALIN R;

ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER CELL; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG TARGETING; GENE SILENCING; HUMAN; IMMUNE SYSTEM; MOLECULARLY TARGETED THERAPY; RNA INTERFERENCE; SOLID TUMOR; TUMOR VASCULARIZATION;

EID: 79955567949     PISSN: None     EISSN: 0976044X     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. S.-S. Feng, S. Chien, Chemotherapeutic engineering: application and further development of chemical engineering principles for chemotherapy of cancer and other diseases, Chemical Engineering Science 58 (2003) 4087-4114.
2. Gomperts, Kramer, Tatham, "Signal Transduction", AP/Elsevier [2002].
3. Gerhard Krauss, Biochemistry of Signal Transduction and Regulation, Wiley-VCH, 1999.
4. John T. Hancock, Cell Signalling, Addison-Wesley, 1998
5. Reddy, J. A.; Westrick, E.; Vlahov, I.; Howard, S. J.; Santhapuram, H. K.; Leamon, C.P. Folate Receptor Specific Anti-Tumor Activity of Folate-Mitomycin Conjugates. Cancer Chemother. Pharmacol. 2006, 58, 229-236.
6. Leamon, C. P.; Reddy, J. A.; Vlahov, I. R.; Vetzel, M.; Parker, N.; Nicoson, J. S.; Xu, L.; Westrick, E. Synthesis and Biological Evaluation of EC72: A New Folate-Targeted Chemotherapeutic. Bioconjugate Chem. 2005, 16, 803-811.
7. American Thoracic Society, news release, June 15, 2009.
8. Sami Sarfaraz, Farrukh Afaq, Vaqar M. Adhami and Hasan Mukhtar. Cannabinoid Receptor as a Novel Target for the Treatment of Prostate Cancer. Cancer Research 65, 1635-1641, March 1, 2005.
9. Jill M. Siegfried, Laura P. Stabile, Pamela A. Hershberger, Mark Nichols and Joan H. Schiller. Targeting the estrogen receptor for lung cancer therapy. Proc Amer Assoc Cancer Res, Volume 46, 2005.
10. José Baselga, Josep Tabernero. Combined Antiangiogenesis and Antiepidermal Growth Factor Receptor Targeting in the Treatment of Cancer. Spain Journal of Clinical Oncology, Vol 25, No 29 (October 10), 2007: pp. 4516-4518.
11. Reimer P, Weissleder R, Lee AS, Buettner S, Wittenberg J, Brady TJ. Role of asialoglycoprotein receptor in hepatic carcinoma. Radiology. 1991 Mar;178(3):769-74.
12. Ritter G, Livingston PO. Ganglioside antigens expressed by human cancer cells. Ganglioside antigens expressed by human cancer cells. Semin Cancer Biol. 1991 Dec;2(6):401-9.
13. Jungbluth AA, Chen YT, Stockert E, Busam KJ, Kolb D, Iversen K, Coplan K, Williamson B, Altorki N, Old LJ. Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues. Int J Cancer. 2001 Jun 15;92(6):856-60.
14. Emiko Hayashi, Yuriko Matsuzaki, Go Hasegawa Tomonori Yaguchi, Sachiko Kurihara, Tomonobu Fujita, Toshiro Kageshita, Makoto Sano and Yutaka Kawakami Identification of a Novel Cancer-Testis Antigen CRT2 Frequently Expressed in Various Cancers Using Representational Differential Analysis Clinical Cancer Research November 2007 13; 626.
15. R. Singh, B.J. Campbell, L.-G. Yu, D.G. Fernig, J.D. Milton, R.A. Goodlad, A.J. FitzGerald and J.M. Rhodes. Cell surface-expressed Thomsen-Friedenreich antigen in colon cancer is predominantly carried on high molecular weight splice variants of CD44. Glycobiology, 2001, Vol. 11, No. 7, 587-592.
16. HM Furneaux, MK Rosenblum, J Dalmau, E Wong, P Woodruff, F Graus, and JB Posner Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration NEJM Volume 322:1844-1851 june 28, 1990 Number 26.
17. Hubert RS, Vivanco I, Chen E, et al. STEAP: a prostatespecific cell-surface antigen highly expressed in human prostate tumors. Proc. Natl. Acad. Sci. USA 1999; 96:14523-8